STIFEL FINANCIAL CORP - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
STIFEL FINANCIAL CORP ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2022$46,000
-36.1%
38,781
-3.3%
0.00%
Q2 2022$72,000
+26.3%
40,121
+43.4%
0.00%
Q1 2022$57,000
-8.1%
27,988
+22.9%
0.00%
Q4 2021$62,000
-49.2%
22,773
-16.5%
0.00%
Q3 2021$122,000
-27.4%
27,268
-5.9%
0.00%
Q2 2021$168,000
-16.8%
28,977
+0.6%
0.00%
Q1 2021$202,000
+15.4%
28,814
-20.8%
0.00%
Q4 2020$175,000
-21.5%
36,362
-5.0%
0.00%
Q3 2020$223,000
-19.2%
38,273
-6.4%
0.00%
-100.0%
Q2 2020$276,000
+31.4%
40,890
+21.7%
0.00%0.0%
Q1 2020$210,000
-22.8%
33,598
+28.6%
0.00%0.0%
Q4 2019$272,000
-13.7%
26,117
+105.6%
0.00%0.0%
Q1 2019$315,000
+43.8%
12,703
+3.1%
0.00%0.0%
Q4 2018$219,000
-59.2%
12,317
-33.4%
0.00%
-50.0%
Q3 2018$537,000
-54.1%
18,495
-27.8%
0.00%
-50.0%
Q2 2018$1,169,000
+17.3%
25,634
+35.6%
0.00%
+33.3%
Q1 2018$997,000
-8.1%
18,902
+18.5%
0.00%0.0%
Q4 2017$1,085,000
-11.4%
15,948
+6.8%
0.00%
-25.0%
Q3 2017$1,224,000
-22.3%
14,928
-11.2%
0.00%
-33.3%
Q2 2017$1,575,000
+90.9%
16,817
+29.6%
0.01%
+100.0%
Q1 2017$825,000
+42.5%
12,979
-0.3%
0.00%
+50.0%
Q4 2016$579,000
+5.1%
13,017
-13.6%
0.00%0.0%
Q3 2016$551,000
+92.0%
15,070
+0.9%
0.00%0.0%
Q1 2016$287,000
-5.3%
14,936
+72.4%
0.00%0.0%
Q4 2015$303,000
-32.8%
8,665
+76.7%
0.00%
-33.3%
Q3 2015$451,000
-36.3%
4,904
-39.1%
0.00%
+50.0%
Q2 2015$708,000
+206.5%
8,056
+95.0%
0.00%
+100.0%
Q4 2014$231,0004,1320.00%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Coppell Advisory Solutions LLC 229$11,0080.00%
View complete list of CLOVIS ONCOLOGY INC shareholders